Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun:Chapter 14:Unit14.14.
doi: 10.1002/0471141755.ph1414s49.

Mouse models of human bladder cancer as a tool for drug discovery

Affiliations

Mouse models of human bladder cancer as a tool for drug discovery

Catherine Seager et al. Curr Protoc Pharmacol. 2010 Jun.

Abstract

Muscle-invasive bladder cancer is a deadly condition in dire need of effective new treatments. This unit contains a description of mouse models suitable for the evaluation of potential new therapies. Included is a genetically engineered mouse model of bladder cancer generated by the delivery of an adenovirus expressing Cre recombinase into the bladder lumen. Also described is an orthotopic mouse model created by the instillation of human bladder tumor cells into the bladder lumen of immune deficient mice. Protocols are also provided on the use of these models for the preclinical evaluation of new chemical entities, with mTOR inhibitors shown as an example.

PubMed Disclaimer

Figures

Figure 14.14.1
Figure 14.14.1
Surgical procedure for instilling cells into the mouse bladder.
Figure 14.14.2
Figure 14.14.2
Placement of a superficial silk purse-string suture around the urethral meatus.
Figure 14.14.3
Figure 14.14.3
Modeling early-stage bladder cancer in mutant mice. (A to C) Representative H&E-stained sections from bladders of a control mouse (uninjected p53flox/flox; Ptenflox/flox) or two representative experimental mice (Adeno-Cre–injected p53flox/flox; Ptenflox/flox) 6 weeks subsequent to delivery of Adeno-Cre (or mock injection for the control). Shown are representative histologic sections from a total of 10 mice in each of the experimental and control groups. Note that the experimental, but not control, mice have a dysplastic and expanded epithelium (arrows) as well as abnormal stroma. Inset, high power view. (D to F) KI67-immunostained adjacent sections show elevated proliferation in the bladder epithelium of the experimental mice relative to the control mice. Inset, high power view. Scale bar, 100 μm. Reprinted with permission from Seager et al. (2009).
Figure 14.14.4
Figure 14.14.4
Rapamycin inhibits bladder tumor progression. Representative examples from the vehicle- or rapamycin-treated mutant mice show the following: (A to D) gross anatomy of bladder tissues/tumors; (E to H) H&E-stained sections; or (I to T) immunostained sections using the indicated antibodies. In all groups, gross analyses of bladder tissues and H&E analyses were done on all control and experimental mice in each group; immunohistochemistry was done on a minimum of four animals from each group; representative data are shown. Scale bars, 100 μm. Reprinted with permission from Seager et al. (2009).

Similar articles

Cited by

References

    1. Ahlering TE, Dubeau L, Jones PA. A new in vivo model to study invasion and metastasis of human bladder carcinoma. Cancer Res. 1987;15:6660–6665. - PubMed
    1. Branda CS, Dymecki SM. Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev. Cell. 2004;6:7–28. - PubMed
    1. Chin J, Kadhim S, Garcia B, Kim YS, Karlik S. Magnetic resonance imaging for detecting and treatment monitoring of orthotopic murine bladder tumor implants. J. Urol. 1991;145:1297–1301. - PubMed
    1. Chong L, Ruping Y, Jiancheng B, Guohong Y, Yougang F, Jiansong W, Xiang G, Jie H, Shusheng X. Characterization of a novel transplantable orthotopic murine xenograft model of a human bladder transitional cell tumor (BIU-87) Cancer Biol. Ther. 2006;4:394–398. - PubMed
    1. Cordon-Cardo C. Molecular alterations associated with bladder cancer initiation and progression. Scand. J. Urol. Nephrol. Suppl. 2008;42:154–165. - PubMed

Publication types

Substances